These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3370071)

  • 21. Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: antioxidant protection by gamma-tocotrienol.
    Newaz MA; Yousefipour Z; Nawal N; Adeeb N
    J Physiol Pharmacol; 2003 Sep; 54(3):319-27. PubMed ID: 14566071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition and pharmacokinetics of cadralazine and individual metabolites in man.
    Schütz H; Faigle JW; Küng W; Theobald W
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):147-53. PubMed ID: 4043143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives.
    Elliott HL; Meredith PA; Howden CW; Lawrie CB; Reid JL
    Int J Clin Pharmacol Res; 1984; 4(1):61-9. PubMed ID: 6469433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
    J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
    Li D; Peng J; Xin HY; Luo D; Zhang YS; Zhou Z; Jiang DJ; Deng HW; Li YJ
    Peptides; 2008 Oct; 29(10):1781-8. PubMed ID: 18625276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
    Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H
    Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid dispersion of rutaecarpine improved its antihypertensive effect in spontaneously hypertensive rats.
    Ding JS; Gao R; Li D; Peng J; Ran LL; Li YJ
    Biopharm Drug Dispos; 2008 Dec; 29(9):495-500. PubMed ID: 19016276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
    Hojo M; Tanaka Y; Katayama O; Teramoto N
    Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of cadralazine in a large group of hypertensive patients chronically treated with cadralazine: advantage over a conventional study in a small group of patients.
    Lecaillon JB; Dubois JP; Darragon T; Motolese M; Racine A; Ducret F; Grouberman D; Cordonnier D; Chanard J; Glorioso M
    Ther Drug Monit; 1991 Mar; 13(2):103-8. PubMed ID: 2053115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effect of losartan in female and male spontaneously hypertensive rats.
    de P Rodrigues SF; dos Santos RA; Silva-Antonialli MM; Scavone C; Nigro D; Carvalho MH; de Cássia Tostes R; Fortes ZB
    Life Sci; 2006 Apr; 78(19):2280-5. PubMed ID: 16337658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y; Kato H
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on uptake and catabolism of vascular histamine in spontaneously hypertensive rats.
    Holcslaw TL; Nichols G; Wilson C
    J Pharmacol Exp Ther; 1985 May; 233(2):352-60. PubMed ID: 3999026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cadralazine (ISF 2469): dose-related antihypertensive activity after single oral administration to patients.
    Catalano M; Parini J; Libretti A
    Eur J Clin Pharmacol; 1983; 24(2):157-61. PubMed ID: 6840161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of cadralazine on the respiration, circulation, kidney, autonomic nervous system, digestive system, blood and so on].
    Nishimori T; Nishimura T; Kobayashi F; Nakano D; Fukuda Y; Sakonjyo H; Nakanishi J; Kimura A; Tsuji H; Higashio T
    Nihon Yakurigaku Zasshi; 1988 Apr; 91(4):221-36. PubMed ID: 3391446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA; Clark AJ; McClymont EL; Staley JL
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
    Beránková K; Szkutová M; Balíková M
    Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of nisoldipine in hypertensive patients with normal and mild to moderate impaired renal function.
    Shionoiri H; Minamisawa K; Masumori S; Satta H; Minamisawa M; Takizawa T; Jinno Y; Takeda K; Nagasawa T; Takasaki I
    Arzneimittelforschung; 1995 Jul; 45(7):785-9. PubMed ID: 8573223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.